Published by Iain Gilbert on 29th July 2025
(Sharecast News) - Drugmaker Astrazeneca said on Tuesday that "strong growth momentum" had continued in H1, with "excellent R&D pipeline delivery" in the year-to-date.
URL: http://www.digitallook.com/dl/news/story/35247104/...